AI-generated summary
The authors report two case studies of adults with palatal myoclonus treated with near-infrared photobiomodulation therapy using 940 nm or 980 nm diode lasers. Both cases showed a reported reduction in contraction frequency and symptoms, with one case followed for seven years. Because the report describes only two patients without a control group, the findings cannot be generalized.
- Participants
- 2
- Who or what was studied
- Two adults with essential palatal myoclonus, a 26-year-old woman and a 28-year-old man
- Wavelengths
- 940, 980 nm
- Limits stated in the abstract
- Only two patients were treated, with no control group, and the authors state that controlled clinical studies are required to confirm efficacy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 940 nm, 980 nm
- Energy density (fluence)
- 8.7 J/cm2, 13.3 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Laser, Near-infrared, Migraine. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.